Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in Sera

被引:9
作者
Natarajan, Renuka [1 ]
Hagman, Sanna [1 ]
Wu, Xingchen [1 ,2 ]
Hakulinen, Ullamari [2 ,3 ]
Raunio, Minna [1 ,4 ]
Helminen, Mika [5 ,6 ]
Rossi, Maija [2 ]
Dastidar, Prasun [2 ]
Elovaara, Irina [1 ,7 ]
机构
[1] Univ Tampere, Neuroimmunol Unit, Sch Med, Tampere, Finland
[2] Tampere Univ Hosp, Dept Neurol, Tampere 33520, Finland
[3] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere 33520, Finland
[4] Seinajoki Cent Hosp, Dept Neurol, Seinajoki 60220, Finland
[5] Univ Tampere, Ctr Sci, Pirkanmaa Hosp Dist, Tampere 33520, Finland
[6] Univ Tampere, Sch Hlth Sci, Tampere 33520, Finland
[7] Tampere Univ Technol, Dept Elect & Commun Engn, Tampere 33520, Finland
关键词
D O I
10.1155/2013/265259
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study was to evaluate diffusion tensor imaging (DTI) indices in the corpus callosum and pyramidal tract in normal-appearing white matter (NAWM) and the caudate nucleus and thalamus in deep grey matter (NADGM) in all MS subtypes and clinically isolated syndrome (CIS). Furthermore, it was determined whether these metrics are associated with clinical measures and the serum levels of candidate immune biomarkers. Apparent diffusion coefficients (ADC) values were significantly higher than in controls in all six studied NAWM regions in SPMS, 4/6 regions in RRMS and PPMS and 2/6 regions in CIS. In contrast, decreased fractional anisotropy (FA) values in comparison to controls were detected in 2/6 NAWM regions in SPMS and 1/6 in RRMS and PPMS. In RRMS, the level of neurological disability correlated with thalamic FA values (r = 0.479, P = 0.004). In chronic progressive subtypes and CIS, ADC values of NAWM and NADGM were associated with the levels of MIF, sFas, and sTNF-alpha. Our data indicate that DTI may be useful in detecting pathological changes in NAWM and NADGM in MS patients and that these changes are related to neurological disability.
引用
收藏
页数:10
相关论文
共 59 条
[1]   Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis [J].
Battaglini, Marco ;
Giorgio, Antonio ;
Stromillo, Maria L. ;
Bartolozzi, Maria L. ;
Guidi, Leonello ;
Federico, Antonio ;
De Stefano, Nicola .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 282 (1-2) :55-60
[2]   Demyelination versus remyelination in progressive multiple sclerosis [J].
Bramow, Stephan ;
Frischer, Josa M. ;
Lassmann, Hans ;
Koch-Henriksen, Nils ;
Lucchinetti, Claudia F. ;
Sorensen, Per S. ;
Laursen, Henning .
BRAIN, 2010, 133 :2983-2998
[3]   Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis [J].
Cader, S. ;
Johansen-Berg, H. ;
Wylezinska, M. ;
Palace, I. ;
Behrens, T. E. ;
Smith, S. ;
Matthews, P. M. .
NEUROIMAGE, 2007, 36 (01) :19-27
[4]   Cortical Diffusion-Tensor Imaging Abnormalities in Multiple Sclerosis: A 3-year Longitudinal Study [J].
Calabrese, Massimiliano ;
Rinaldi, Francesca ;
Seppi, Dario ;
Favaretto, Alice ;
Squarcina, Letizia ;
Mattisi, Irene ;
Perini, Paola ;
Bertoldo, Alessandra ;
Gallo, Paolo .
RADIOLOGY, 2011, 261 (03) :891-898
[5]   Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI [J].
Cercignani, M ;
Bozzali, M ;
Iannucci, G ;
Comi, G ;
Filippi, M .
JOURNAL OF NEUROLOGY, 2002, 249 (07) :875-883
[6]   Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis [J].
Ciccarelli, O. ;
Wheeler-Kingshott, C. A. ;
McLean, M. A. ;
Cercignani, M. ;
Wimpey, K. ;
Miller, D. H. ;
Thompson, A. J. .
BRAIN, 2007, 130 :2220-2231
[7]   Investigation of MS normal-appearing brain using diffusion tenser MRI with clinical correlations [J].
Ciccarelli, O ;
Werring, DJ ;
Wheeler-Kingshott, CAM ;
Barker, GJ ;
Parker, GJM ;
Thompson, AJ ;
Miller, DH .
NEUROLOGY, 2001, 56 (07) :926-933
[8]   Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects [J].
Cohen, Jeffrey A. ;
Reingold, Stephen C. ;
Polman, Chris H. ;
Wolinsky, Jerry S. .
LANCET NEUROLOGY, 2012, 11 (05) :467-476
[9]   New technologies for biomarker discovery in multiple sclerosis [J].
Comabella, Manuel ;
Racke, Michael K. .
JOURNAL OF NEUROIMMUNOLOGY, 2012, 248 (1-2) :1-1
[10]   Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine [J].
Comabella, Manuel ;
Vandenbroeck, Koen .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (05) :484-491